Press Release

Genetic Genealogy Testing Market to Grow with a CAGR of 7.81% through 2028

Surging demand for DNA testing and high-end investment for research and development activities is expected to drive the Global Genetic Genealogy Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Genetic Genealogy Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Genetic Genealogy Market stood at USD 959.39 Million in 2022 and is anticipated to grow with a CAGR of 7.81% in the forecast period, 2024-2028.  The increasing prevalence of chronic diseases is identified as a major driver during the forecast period. The ongoing development of pharmacogenomics, which involves studying genetics and the effects of medication on the human body, is witnessing a rise to meet the global population's needs.

The growing awareness among consumers about the advantages of preventive healthcare is contributing to the demand for the genetic genealogy market in the next five years. Substantial investments by leading authorities in research and development activities aimed at upgrading existing infrastructure are significant factors propelling the growth of the genetic genealogy market.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Genetic Genealogy Market.”

 

Genetic genealogy plays a crucial role in enhancing the quality of healthcare services provided to patients, creating lucrative opportunities for market growth. As the demand for quality healthcare services continues to rise, the integration of genetic genealogy allows healthcare facilities to deliver personalized treatments that meet the highest standards of effectiveness. By leveraging genetic genealogy, healthcare providers can tailor their services to individual patients, ensuring optimal outcomes and patient satisfaction. Industry leaders are actively embracing the study of genetic genealogy to develop innovative products that cater to the unique needs of patients.

Genetic genealogy serves as a vital tool in the creation of genealogy data. Genealogy service providers employ various analysis methods, including oral interviews, genetic genealogy, and family history information, among others. By collecting DNA samples from individuals, genetic genealogy enables the study of DNA changes and the gathering of valuable biological information. The analysis helps uncover ancestral connections and shed light on the intricate details of one's heritage.

Genetic genealogy offers a multitude of advantages, thus driving the increasing global demand for its applications. In the realm of medication, genetic genealogy provides invaluable insights that aid caregivers and patients in tailoring treatment and medical care to the individual and their family. Moreover, effective genetic genealogy can offer diagnostic information, empowering individuals to take necessary medication or treatment. As the prevalence of cancer and heart diseases continues to rise in Canada, genetic genealogy becomes even more important in understanding and managing these conditions. According to the Canadian Cancer Society, cancer accounted for 28.2% of deaths in Canada, with an estimated 229,200 new cancer cases and 84,600 deaths projected in 2021. However, advancements in treatments such as biological drugs and chemotherapy are expected to decrease the mortality rate by 37% in men and 22% in women by 2021.

The growing awareness of cancer development and DNA mutations among individuals worldwide further emphasizes the significance of DNA testing. DNA testing allows for the estimation of an individual's likelihood of developing cancer and provides valuable insights into inherited cancer susceptibility syndromes. By understanding the patterns of cancer development, individuals can proactively manage their cancer risks. Next-generation sequencing (NGS) represents the latest breakthrough in DNA-testing technology, encompassing whole-exome sequencing and whole-genome sequencing. NGS enables comprehensive evaluations of individuals with personal or family history, helping identify genetic markers associated with breast and ovarian cancer susceptibility. With continuous technological advancements in genealogy, the market is poised to witness substantial growth with a higher compound annual growth rate (CAGR).

However, it is important to acknowledge potential challenges that could impede market growth. Data breaches of historical records and genealogical data, as well as the negative impact of DNA testing on family and personal relationships, pose significant concerns. DNA testing results have the potential to strain relationships within families, as they may reveal risk statuses and genetic disorders that some family members may not be willing to confront. The disclosure of such sensitive information can encroach upon individual autonomy and privacy, necessitating careful consideration of ethical and privacy implications. By providing detailed insights into ancestry and genetic predispositions, genetic genealogy continues to revolutionize the healthcare industry. As the market evolves, striking a balance between technological advancements and privacy considerations will be crucial to ensuring the responsible and ethical use of genetic genealogy data.

 

The Global Genetic Genealogy Market is segmented into test type, application, end user, regional distribution, and company.

Based on test type, Autosomal DNA testing has emerged as the dominant method in the genetic testing market in 2022. This is primarily due to its origin in the nucleus, where it represents an equal contribution of genetic material from both parents to their offspring. Each individual inherits 50% of their nuclear DNA from their father and 50% from their mother, resulting in a unique blend of genetic information.  This fascinating pattern of inheritance continues through each generation, leading to approximately 25% of DNA inherited from each grandparent, 12.5% from each great-grandparent, and so on. Autosomal DNA testing is of utmost importance when it comes to accurately estimating a family tree, as it allows us to trace our ancestry through the diverse genetic contributions of our ancestors.

On the other hand, Y-chromosome DNA testing focuses exclusively on the paternal line. The Y-chromosome is passed down virtually unchanged from father to son, creating a direct link between male relatives across generations. For instance, an individual shares the same Y-DNA as their father, grandfather, great-grandfather, as well as their paternal uncle and grandfather's brothers. This type of testing holds significant value in studying family names and lineage in patrilineal societies. However, it is important to note that Y-chromosome DNA testing does not provide detailed information about which specific brother an individual descended from within the family, as all males within the family share the same Y-DNA. This limitation underscores the importance of autosomal DNA testing in revealing the broader genetic diversity and complexity within our family trees.

 

Based on region, North America segment is expected to grow during the forecast period. The North America region is anticipated to dominate the market during the forecast period of 2024-2028. This can be attributed to the presence of key market players in the region, coupled with a well-developed healthcare infrastructure, which serves as the primary driver behind the substantial growth of the genetic genealogy market. Furthermore, robust economic growth and significant investments by major players have led to a notable upsurge in market expansion. Additionally, heightened consumer awareness regarding the advantages of quality treatment, combined with favorable reimbursement policies for healthcare services, has contributed to the upward trajectory of market growth.

North America accounted for the largest market share and is projected to grow during the forecast period. The presence of major market players in the region, along with a well-developed healthcare infrastructure, is the main factor responsible for the rapid growth of the genealogy products and services market. Strong economic growth and substantial investments by the major players are driving market growth. Consumer awareness of the benefits of quality treatment, combined with the availability of attractive reimbursement policies for healthcare services, is contributing to the market’s growth.

 

Major companies operating in Global Genetic Genealogy Market are:

  •     23&Me Inc.
  •     Ancestry.com
  •     MyHeritage
  •     Sequencing. Com
  •     FTDNA
  •     DNASolves
  •     Living DNA
  •     FindmyPast
  •     Familysearch
  •     Geneanet

 Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global genetic genealogy market is projected to witness substantial growth during the forecast period. The increasing prevalence of chronic diseases is a key driving factor in this period. The ongoing development of pharmacogenomics, which involves the study of genetics and the impact of medication on the human body, is gaining momentum to meet the global population's needs. The growing awareness among consumers about the benefits of preventive healthcare is contributing to the rising demand for the genetic genealogy market in the next five years. Furthermore, significant investments by leading authorities in research and development activities to enhance existing infrastructure are driving the growth of the genetic genealogy market. Genetic genealogy plays a crucial role in improving the quality of healthcare services, presenting lucrative opportunities for market growth as the demand for quality healthcare services remains high. Additionally, technological advancements in genealogy offer new prospects for the market to achieve higher growth rates.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Genetic Genealogy Market Segmented By Test Type (Autosomal DNA Test, Y- chromosome DNA Test, Mitochondrial DNA Test), By Application (Heredity & Genetic Disorders, Paternal/Maternal Lineages, Ancestral Origins, Others), By End User (Direct-to-Consumer Testing Companies, Law Enforcement Agencies, Research Institutes & Academic Organizations, Others), By Region and Competition, Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Genetic Genealogy Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Genetic Genealogy Market.

 

Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: https://www.techsciresearch.com           

Relevant News